Peter Ruestow
Impact in
- Modeling and Simulation top 5%
- COVID-19 epidemiological studies
-
- Lung Cancer Treatments and Mutations
- Occupational and environmental lung diseases
- Lung Cancer Diagnosis and Treatment
Papers in
-
- COVID-19 Clinical Research Studies 2
- Co-authors
- Amy K. Madl (1 shared paper)Aaron Chapman (1 shared paper)Kathie Sun (1 shared paper)Dallas M. Cowan (1 shared paper)Brent L. Finley (3 shared papers)Jennifer S. Pierce (3 shared papers)Tristan D. McPherson (2 shared papers)Janna L. Kerins (2 shared papers)
- Journals
- MMWR Morbidity and Mortality Weekly Report (3 papers)Journal of Occupational and Environmental Medicine (2 papers)Emerging infectious diseases (2 papers)American Journal of Industrial Medicine (1 paper)Regulatory Toxicology and Pharmacology (1 paper)
- Partner nations
- United StatesNetherlandsItaly
In The Last Decade
Peter Ruestow
14 papers receiving 403 citations
Peers
Comparison fields: 5 of 88
- Modeling and Simulation 49
- Pulmonary and Respiratory Medicine 148
- Oncology 79
- Infectious Diseases 52
- Cancer Research 37
Countries citing papers authored by Peter Ruestow
This map shows the geographic impact of Peter Ruestow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Ruestow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Ruestow more than expected).
Fields of papers citing papers by Peter Ruestow
This network shows the impact of papers produced by Peter Ruestow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Ruestow. The network helps show where Peter Ruestow may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Ruestow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 186 | |
| 2 | 2020 | 96 | |
| 3 | 2010 | 29 | |
| 4 | 2015 | 25 | |
| 5 | 2016 | 24 | |
| 6 | 2017 | 15 | |
| 7 | 2016 | 14 | |
| 8 | 2013 | 9 | |
| 9 | 2021 | 5 | |
| 10 | 2020 | 4 | |
| 11 | 2012 | 4 | |
| 12 | 2023 | 4 | |
| 13 | 2017 | 2 | |
| 14 | 2023 | 1 | |
| 15 | 2021 | 0 |
About Peter Ruestow
Peter Ruestow is a scholar working on Epidemiology, Infectious Diseases, Health, Radiological and Ultrasound Technology and Pulmonary and Respiratory Medicine, having authored 15 papers that have together received 418 indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (2 papers), COVID-19 epidemiological studies (2 papers), COVID-19 Clinical Research Studies (2 papers), Occupational Health and Safety Research (2 papers), Air Quality and Health Impacts (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper), Toxic Organic Pollutants Impact (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Modeling and Simulation (49 citations), Pulmonary and Respiratory Medicine (148 citations), Oncology (79 citations), Infectious Diseases (52 citations) and Cancer Research (37 citations). Peter Ruestow has collaborated with scholars based in United States, Netherlands and Italy. Frequent co-authors include Amy K. Madl, Aaron Chapman, Kathie Sun, Dallas M. Cowan, Brent L. Finley, Jennifer S. Pierce, Tristan D. McPherson, Janna L. Kerins, Marielle Fricchione and M. Allison Arwady. Their work appears in journals such as MMWR Morbidity and Mortality Weekly Report, Journal of Occupational and Environmental Medicine, Emerging infectious diseases, American Journal of Industrial Medicine and Regulatory Toxicology and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.